These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6379568)

  • 21. Comparison of serum and prostatic levels of tobramycin.
    Williams CB; Litvak AS; McRoberts JW
    Urology; 1979 Jun; 13(6):589-91. PubMed ID: 109981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lomefloxacin concentration in human prostatic tissue following 3-day administration].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1993 Jan; 39(1):97-9. PubMed ID: 7681621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of storage time at -20 degrees C on the determination of serum concentrations of tobramycin in the presence of 6 beta-lactams].
    Forey F; Coulet M; Freney J; Brun Y; Fleurette J
    Pathol Biol (Paris); 1983 May; 31(5):404-12. PubMed ID: 6353332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of EMIT versus bioassay to evaluate inactivation of tobramycin by piperacillin.
    Anders RJ; Lau A; Sharifi R; Lee M
    Ther Drug Monit; 1987 Dec; 9(4):472-7. PubMed ID: 3321583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Concentration of cefoperazone in various tissues of the urogenital system (author's transl)].
    Schalkhäuser K; Adam D
    Arzneimittelforschung; 1981; 31(10):1770-2. PubMed ID: 6459099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gentamicin and tobramycin pharmacokinetics in patients with cystic fibrosis.
    Bauer LA; Piecoro JJ; Wilson HD; Blouin RA
    Clin Pharm; 1983; 2(3):262-4. PubMed ID: 6883955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of prostatic massage on serum complexed prostate-specific antigen levels.
    Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoğlu U
    Urology; 2005 Dec; 66(6):1234-8. PubMed ID: 16360449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Zinc in prostatic physiopathology. I. Role of zinc in the physiology and biochemistry of the prostatic gland].
    Maganto Pavón E
    Arch Esp Urol; 1979; 32(2):143-52. PubMed ID: 464667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do prostatic infarction, prostatic inflammation and prostate morphology play a role in acute urinary retention?
    Tuncel A; Uzun B; Eruyar T; Karabulut E; Seckin S; Atan A
    Eur Urol; 2005 Aug; 48(2):277-83; discussion 283-4. PubMed ID: 15964132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trace elements in prostatic tissue and plasma in prostatic diseases of man.
    Jafa A; Mahendra NM; Chowdhury AR; Kamboj VP
    Indian J Cancer; 1980 Mar; 17(1):34-7. PubMed ID: 7399553
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of a new hypersensitive assay for the detection of prostate specific antigen in prostate cancer.
    Arai Y; Onishi H; Oishi K; Takeuchi H; Yoshida O
    Jpn J Clin Oncol; 1993 Apr; 23(2):110-5. PubMed ID: 7685834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland.
    Bjartell A; Johansson R; Björk T; Gadaleanu V; Lundwall A; Lilja H; Kjeldsen L; Udby L
    Prostate; 2006 May; 66(6):591-603. PubMed ID: 16388501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer.
    Heracek J; Hampl R; Hill M; Starka L; Sachova J; Kuncova J; Eis V; Urban M; Mandys V
    Steroids; 2007 Apr; 72(4):375-80. PubMed ID: 17368496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concentration of ofloxacin in canine prostate tissue and prostate fluid after intraprostatic injection of biodegradable sustained-releasing microspheres containing ofloxacin.
    Bahk JY; Hyun JS; Lee JY; Kim J; Cho YH; Lee JH; Park JS; Kim MO
    J Urol; 2000 May; 163(5):1560-4. PubMed ID: 10751888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diffusion of co-tetroxazin into prostatic tissue (author's transl)].
    Riedmiller H; Vergin H; Jacobi GH
    Arzneimittelforschung; 1981; 31(5):864-5. PubMed ID: 6168272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in serum prostate-specific antigen level after prostatectomy in patients with benign prostatic hyperplasia.
    Hosseini SY; Salimi M; Hosseini Moghaddam SM
    Urol J; 2005; 2(4):183-8. PubMed ID: 17602426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.
    Walz PH; Björk P; Gunnarsson PO; Edman K; Hartley-Asp B
    Clin Cancer Res; 1998 Sep; 4(9):2079-84. PubMed ID: 9748122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enrofloxacin concentrations in dogs with normal prostate and dogs with chronic bacterial prostatitis.
    Dorfman M; Barsanti J; Budsberg SC
    Am J Vet Res; 1995 Mar; 56(3):386-90. PubMed ID: 7771709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.